![]() |
市場調查報告書
商品編碼
2026837
家用氧氣濃縮機市場預測至2034年-按產品類型、銷售形式、技術、最終用戶和地區分類的全球分析Homecare Oxygen Concentrators Market Forecasts to 2034 - Global Analysis By Product, Marketing Type, Technology, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球家用氧氣濃縮機市場規模將達到 23 億美元,並在預測期內以 8% 的複合年成長率成長,到 2034 年將達到 42 億美元。
家用氧氣濃縮機市場是指提供攜帶式和固定式製氧機的行業,這些設備旨在讓呼吸系統疾病患者在家中舒適地接受高濃度氧氣治療。主要廠商提供功能和流量各異的多種產品,以滿足不同類型患者的需求。
根據世界衛生組織(WHO)的數據,2019 年全球約有 323 萬人死於慢性阻塞性肺病(COPD)。
全球老化進程
隨著老年人口的成長,慢性阻塞性肺病(COPD)和其他需要氧氣療法的呼吸系統疾病的盛行率也在上升。對於需要額外吸氧的患者來說,家用氧氣濃縮機提供了一種實用且高效的解決方案,使他們能夠在舒適的家中管理自身病情。此外,這些人口趨勢也推動了對居家醫療解決方案的需求成長。
設備高成本
家用氧氣濃縮機昂貴,限制了經濟困難人群的購買。此外,醫療保險公司的報銷問題也會阻礙其廣泛普及。這些醫療設備需要長期居家使用,但其高昂的價格使得部分患者無法承擔,阻礙了市場成長。因此,要克服這些障礙,擴大家用氧氣濃縮機的普及範圍,就需要解決價格承受能力問題並改善報銷政策。
與老化相關的呼吸系統疾病
隨著越來越多的老年人希望在家安享晚年,對便利可靠的家用氧氣療法解決方案的需求激增。家用氧氣濃縮機機輕鬆易攜,取代了笨重的氧氣罐,讓患者自由活動。憑藉技術進步,製造商可以開發出靜音、節能、輕巧的設備,以滿足日益成長的高效家用呼吸護理需求。全球醫療保健分散化和注重成本效益的趨勢正在推動這一市場擴張。
替代技術的興起
傳統家用氧氣濃縮機面臨著來自新興的穿戴式式和可攜式氧氣輸送技術以及其他有望降低成本、提升便利性的替代技術的競爭。醫療產業的報銷問題和監管變化也可能影響市場擴張。遠距遠端醫療服務和遠端患者監護的興起也可能影響家用氧氣濃縮機的需求。為了降低新興市場威脅帶來的風險,該行業的製造商必須保持柔軟性,以適應不斷發展的技術。
導致呼吸系統併發症的病毒傳播增加了對氧氣療法設備(例如家用氧氣濃縮機)的需求。這種需求的成長正在擴大市場,越來越多的人選擇在家中進行長期氧氣療法。為了滿足這一需求,製造商正在大幅提高產量,攜帶式和方便用戶使用設計的創新也備受關注。此外,疫情加速了遠端醫療服務的普及,促進了呼吸系統疾病的遠端監測和管理,從而對家用氧氣濃縮機市場產生了影響。
在預測期內,攜帶式家用氧氣濃縮機市場預計將成為最大的細分市場。
由於攜帶式家用氧氣濃縮機具有便攜性和便利性等優勢,其氧氣濃縮機正經歷顯著成長。呼吸系統疾病患者更傾向於使用攜帶式氧氣療法設備,因為它們能讓患者在接受維持生命的氧氣治療的同時,保持積極的生活方式。此外,人們對家用氧氣療法益處的認知不斷加深,也增加了對攜帶式解決方案的需求,從而推動了市場擴張。
在預測期內,脈搏血流細分市場預計將呈現最高的複合年成長率。
由於脈衝式製氧機效率更高、更便攜,家用氧氣濃縮機市場正經歷顯著成長。脈衝式製氧機僅在使用者吸氣時才供氧,從而最大限度地利用氧氣並延長制氧機的使用壽命。這項特性使其成為間歇性吸氧患者更經濟、更節能的選擇。脈衝式製氧機在家用氧氣濃縮機市場的佔有率擴大,主要歸功於居家醫療解決方案日益成長的趨勢。
亞太地區家用氧氣濃縮機市場正快速成長,這主要得益於人口老化、呼吸系統疾病增加以及消費者對居家醫療方案日益成長的認知。攜帶式氧氣濃縮機的改進和技術進步是推動市場成長的主要動力。此外,持續蔓延的新冠肺炎疫情也增加了對呼吸照護產品的需求,進一步促進了亞太市場的成長。與主要醫療機構和行業相關人員的合作也有助於提高這些設備的市場滲透率。
人們對居家醫療日益成長的興趣、人口老化以及呼吸系統疾病盛行率的上升,共同推動了歐洲家用氧氣濃縮機市場的強勁成長。新冠疫情凸顯了呼吸系統照護的重要性,導致家用氧氣濃縮機的需求激增。此外,支持居家醫療服務的醫療基礎設施完善以及有利的報銷政策也促進了市場的強勁成長。
According to Stratistics MRC, the Global Homecare Oxygen Concentrators Market is accounted for $2.3 billion in 2026 and is expected to reach $4.2 billion by 2034 growing at a CAGR of 8% during the forecast period. The Homecare Oxygen Concentrators market refers to the industry that provides portable and stationary devices designed to deliver concentrated oxygen to individuals with respiratory conditions in the comfort of their homes. Major industry players provide a variety of products with different features and flow rates to meet the needs of different types of patients.
According to the World Health Organization, nearly 3.23 million deaths were caused due to the Chronic Obstructive Pulmonary Disease (COPD), globally, in 2019.
Growing aging population globally
As the elderly population increases, there is a rising prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD) and other respiratory conditions that necessitate oxygen therapy. For those in need of extra oxygen, homecare oxygen concentrators provide a practical and efficient solution that enables them to manage their conditions from the comfort of their own homes. Additionally, the demand for home healthcare solutions is increasing due to this demographic trend.
High cost associated with the devices
Homecare oxygen concentrators can be expensive for consumers, limiting accessibility for individuals with lower financial means. Further impeding widespread adoption could be reimbursement challenges from health insurance companies. The expense of these necessary medical devices for long-term use at home prevents some patients from affording them, which hinders market growth. Therefore, overcoming this barrier and guaranteeing greater access to homecare oxygen concentrators requires addressing affordability issues and improving reimbursement policies.
Respiratory disorders of aging population
As more elderly individuals prefer to age in place, the demand for convenient and reliable home oxygen therapy solutions has surged. In place of bulky oxygen tanks, homecare oxygen concentrators provide a lightweight, convenient substitute that preserves patients' freedom and mobility. Manufacturers can benefit from technological advancements by creating devices that are noise-free, energy-efficient, and lightweight, which will help meet the growing demand for efficient home respiratory care. The growing emphasis on healthcare decentralization and cost-effective solutions worldwide is driving this market's expansion.
Emergence of alternative technologies
Conventional home oxygen concentrators face competition from emerging wearable and portable oxygen delivery technologies, as well as possible cost- and convenience-saving alternatives. The healthcare industry's reimbursement problems and regulatory changes could also affect the market's expansion. The need for homecare oxygen concentrators may be impacted by the move toward telehealth services and remote patient monitoring. To reduce the risk posed by emerging market threats, manufacturers in this industry must remain flexible in their adaptation to evolving technologies.
The need for oxygen therapy supplies, such as home oxygen concentrators, has increased due to the virus's surge in respiratory complications. The market has expanded as a result of the rising demand, with more people choosing home-based solutions for long-term oxygen therapy. To meet this demand, manufacturers have seen a spike in production, and innovations in portable and user-friendly designs are receiving more attention. Furthermore, the pandemic has expedited the uptake of telehealth services, impacting the homecare oxygen concentrator market by encouraging remote respiratory condition monitoring and management.
The portable home oxygen concentrator segment is expected to be the largest during the forecast period
Because of its benefits of portability and convenience, the portable home oxygen concentrator market within the homecare oxygen concentrator market has experienced significant growth. Patients with respiratory disorders like portable oxygen therapy units because they enable them to continue living an active lifestyle while receiving vital oxygen treatment. In addition, a greater knowledge of the advantages of home oxygen therapy have fueled demand for portable solutions and expanded the market.
The pulse flow segment is expected to have the highest CAGR during the forecast period
The pulse flow segment in the Homecare Oxygen Concentrators market has experienced substantial growth due to its enhanced efficiency and portability. By delivering oxygen only when the user inhales, pulse flow devices maximize oxygen consumption and prolong concentrator life. Because of this feature, they are more economical and energy-efficient for patients with sporadic oxygen needs. Pulse flow concentrators' growing market share in the homecare oxygen concentrators sector is largely due to the growing trend toward at-home healthcare solutions.
The Asia-Pacific (APAC) homecare oxygen concentrator market has grown rapidly due to factors like an aging population, a rise in respiratory disorders, and increased consumer awareness of at-home healthcare options. The market has grown as a result of improvements in portable oxygen concentrators and technological breakthroughs. In addition, the ongoing COVID-19 pandemic has increased the need for respiratory care supplies, which is driving the APAC market. Partnerships between major healthcare providers and industry players have also helped these devices gain traction in the market.
A growing emphasis on home-based healthcare, an aging population, and the rising prevalence of respiratory disorders have all contributed to Europe's Homecare Oxygen Concentrators market's lucrative growth. The need for homecare oxygen concentrators has increased as a result of the COVID-19 pandemic's emphasis on the significance of respiratory care. The healthcare infrastructure that supports homecare services and favorable reimbursement policies have also contributed to the market's strong growth.
Key players in the market
Some of the key players in Homecare Oxygen Concentrators market include Air Water Inc, AVIC Jianghang, Beijing North Star, Besco Medical Co., BOC Healthcare (The Linde Group), Chart Industries Inc , Drive DeVibiss Healthcare Inc, Foshan Kaiya, GCE Group, Inogen Inc, Inova Labs Inc. (ResMed), Invacare, Koninklijke Philips N.V., Longfian Scitech Co, NIDEK Medical Products, Inc, O2 Concepts , Philips Respironics, Precision Medical Inc , Teijin and Yuwell (iangsu Yuyue Medical Equipment and Supply Co., Ltd.)
In August 2023, Chart Industries, Inc, a leading global engineering design firm, announced that it has executed a Memorandum of Understanding ("MOU") with 8 Rivers Capital, LLC, to evaluate 8 Rivers' portfolio of proprietary licensable technologies and processes and identify where Chart's technologies and systems can complement or bring added value to the 8 Rivers offerings. This collaboration includes developing equipment for 8 Rivers technologies backed up by Chart's decades of experience in the design and manufacture of cryogenic, compression and process technologies, to assist 8 Rivers in delivering a reliable and cost-effective solution to their customers.
In July 2023, Inogen has signed a definitive agreement for the acquisition of France-based company Physio-Assist in a deal valued at nearly $45m, to bolster its respiratory product portfolio. As per the deal, Physio-Assist is entitled to receive nearly $32m in cash from Inogen at closing, as well as payments on meeting milestones linked to clearance from the Food and Drug Administration for the device.